Medicamen Organics Board of Directors
Get the latest insights into the leadership at Medicamen Organics. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Bal Kishan Gupta | Chairman & Managing Director |
| Mr. Ashutosh Gupta | Whole Time Director |
| Mr. Shailesh Harimohan Gaur | Executive Director |
| Mr. Rakesh Kumar | Independent Director |
| Mr. Rajinder Kumar Gupta | Independent Director |
| Mr. Sachin Gupta | Independent Director |
| Ms. Sneh Gaur | Non Exe.Non Ind.Director |
Medicamen Organics Share price
MEDIORG
37
0.55 (1.51%)NSE
BSE
Last updated on 3 Sep, 2025 | 15:20 IST
BUYSELL
Today's High
37.00
Today's Low
34.85
52 Week Low
19.60
52 Week High
72.60
The current prices are delayed, login to your account for live prices
LoginMedicamen Organics FAQs
The board at Medicamen Organics consists of experienced professionals, including Mr. Bal Kishan Gupta , Mr. Ashutosh Gupta , and others, overseeing the company’s strategic and corporate governance.
Directors at Medicamen Organics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Bal Kishan Gupta is the current chairman at Medicamen Organics.
Executive directors at Medicamen Organics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Medicamen Organics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Medicamen Organics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.